Translational analysis of esophageal adenocarcinoma (EAC) patients treated with oxaliplatin and capecitabine (Xelox) +/- the dual ErbB inhibitor AZD8931 in the DEBIOC study by Lavery, A, Stevenson, L, McManus, D, Logan, GE, Walker, SM, Jellema, GL, Van Schaeybroeck, S, Virdee, PS, Middleton, MR, Elhussein, L, Turbitt, J, Colinson, D, Miedzybrodzka, Z, Petty, RD, Harkin, PD, Kennedy, RD, Eatock, MM, Thomas, AL, Turkington, RC